Endocrinology and Metabolism conditions, page 5 of 5
6 conditions on this page, alphabetically from Thyrotoxicosis to Xanthinuria. Each entry below describes the condition in full.
On this page
Thyrotoxicosis
In clinical terms, thyrotoxicosis is described as follows: A thyroid gland disease that is characterized by excess thyroid hormone.
Classification
Ontology identifier: DOID:7997 (Human Disease Ontology).
Classification path: disease of anatomical entity › endocrine system disease › thyroid gland disease.
Specialty: Endocrinology and Metabolism
Broader conditions
Medical codes
- ICD-10-CM: E05.9
- ICD-9-CM: 242
- MeSH: D013971
- SNOMED CT: 154655004
Care at Weyland-Yutani Health System
Treatment of thyrotoxicosis begins with an evaluation in Endocrinology and Metabolism. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Questions about thyrotoxicosis? Call your nearest Weyland-Yutani location and ask for Endocrinology and Metabolism.
Reference links
Type 2 diabetes mellitus
A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Patients with type 2 diabetes mellitus are cared for through our Endocrinology and Metabolism service line.
Also known as
- insulin resistance
- NIDDM
- non-insulin-dependent diabetes mellitus
- type 2 diabetes
- type II diabetes mellitus
Classification
Ontology identifier: DOID:9352 (Human Disease Ontology).
Classification path: disease of metabolism › inherited metabolic disorder › carbohydrate metabolic disorder › glucose metabolism disease › diabetes mellitus.
Specialty: Endocrinology and Metabolism
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: E11
- MeSH: D003924
- OMIM: 125853
- OMIM: 601283
- OMIM: 601407
- OMIM: 603694
- OMIM: 608036
- SNOMED CT: 44054006
Care at Weyland-Yutani Health System
Treatment of type 2 diabetes mellitus begins with an evaluation in Endocrinology and Metabolism. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about type 2 diabetes mellitus. Bring a list of current medications and any previous test results.
Reference links
Tyrosinemia
In clinical terms, tyrosinemia is described as follows: an amino acid metabolic disorder that involves impaired break down of the amino acid tyrosine.
Classification
Ontology identifier: DOID:9275 (Human Disease Ontology).
Classification path: disease of metabolism › inherited metabolic disorder › amino acid metabolic disorder.
Specialty: Endocrinology and Metabolism
Broader conditions
Medical codes
- ICD-10-CM: E70.21
- SNOMED CT: 190694001
Care at Weyland-Yutani Health System
Endocrinology and Metabolism specialists lead care for tyrosinemia. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about tyrosinemia. Bring a list of current medications and any previous test results.
Reference links
Vitamin K deficiency bleeding
A nutritional deficiency disease that is characterized by easy bleeding due to an inability to form blood clots caused by vitamin K deficiency, occurs most commonly in newborns, and has_material_basis_in deficiency of vitamin K secondary to liver prematurity, lack of vitamin K in a breastmilk diet, largely sterile gut, malabsorption, diarrhea, chronic illness, menorrhagia, chronic kidney disease, and some medications. This page summarizes how vitamin K deficiency bleeding is classified and the care available at Weyland-Yutani Health System.
Also known as
- deficiency of vitamin K
- vitamin K deficiency
- vitamin K deficiency hemorrhagic disease
Classification
Ontology identifier: DOID:11249 (Human Disease Ontology).
Classification path: disease of metabolism › acquired metabolic disease › nutrition disease › nutritional deficiency disease.
Specialty: Endocrinology and Metabolism
Broader conditions
Medical codes
- ICD-10-CM: E56.1
- ICD-9-CM: 269.0
- MeSH: D014813
- SNOMED CT: 52675005
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, vitamin K deficiency bleeding is managed by Endocrinology and Metabolism with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Questions about vitamin K deficiency bleeding? Call your nearest Weyland-Yutani location and ask for Endocrinology and Metabolism.
Reference links
Wolman disease
Overview. A lysosomal acid lipase deficiency characterized by infantile onset of rapidly progressive accumulation of cholesteryl esters and triglycerides throughout the body, resulting in hepatosplenomegaly, severe malnutrition, jaundice, vomiting, diarrhea, steatorrhea. Death usually occurs within the first year of life. Weyland-Yutani Health System offers diagnosis and ongoing care for Wolman disease.
Also known as
- Acid esterase deficiency
- Acid lipase deficiency
- acute infantile lysosomal acid lipase deficiency
- complete cholesterol ester hydrolase deficiency
- complete LAL deficiency
- complete LIPA deficiency
- complete lysosomal acid lipase deficiency
- Wolman xanthomatosis
- Wolman's disease
- Wolman's or triglyceride storage type III disease
- Xanthomatosis, familial
Classification
Ontology identifier: DOID:14497 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal recessive disease › lysosomal acid lipase deficiency.
Specialty: Endocrinology and Metabolism
Broader conditions
Medical codes
- ICD-10-CM: E75.5
- MeSH: D015223
- OMIM: 620151
- SNOMED CT: 82500001
Care at Weyland-Yutani Health System
Endocrinology and Metabolism specialists lead care for Wolman disease. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have Wolman disease, contact your primary care provider or schedule a visit with Endocrinology and Metabolism.
Reference links
Xanthinuria
A purine-pyrimidine metabolic disorder characterized by deficiency of xanthine oxidase, resulting in excretion of large amounts of xanthine in the urine and the formation of xanthine stones. Our Endocrinology and Metabolism team evaluates and manages xanthinuria.
Also known as
- classic xanthinuria
- hereditary xanthinuria
- xanthine dehydrogenase deficiency
- xanthine oxidase deficiency
Classification
Ontology identifier: DOID:0060236 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal recessive disease.
Specialty: Endocrinology and Metabolism
Broader conditions
Medical codes
- OMIM: PS278300
- SNOMED CT: 190919008
Care at Weyland-Yutani Health System
Endocrinology and Metabolism specialists lead care for xanthinuria. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
Related articles
When to seek care
If you or a family member may have xanthinuria, contact your primary care provider or schedule a visit with Endocrinology and Metabolism.
Reference links